Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab

Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management

(2011) Alessandra Vultaggio et al.   Current Opinion in Allergy and Clinical Immunology

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions

(2009) A. Vultaggio et al.   ALLERGY

Immunogenicity of rituximab in patients with severe pemphigus

(2009) Enno Schmidt et al.   CLINICAL IMMUNOLOGY

Monoclonal antibody-induced cytokine-release syndrome

(2009) Peter J Bugelski et al.   Expert Review of Clinical Immunology

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment

(2009) Patrick J. Brennan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and Prediction

(2008) Mark Wing   Journal of Immunotoxicology

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

(2008) Gopi Shankar et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

(2008) Christine H. Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE